Avacta Group Plc (AVCT)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Avacta Group Plc (AVCT) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011269
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:46
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Avacta Group Plc (Avacta) is a developer therapeutic molecules used in a wide range of life sciences applications in research and diagnostics. The company offers products which include optim and sensipod. It also develops UCB celltech, which is an analytical instrument. Avacta’s sensipod is an in-clinical blood testing system that delivers ELISA tests. The company offers intellectual property relating to an alternative to antibodies. It develops reagents and diagnostics which are used in affinity chromatography, protein to protein interactions, immunoassay and rapid diagnostic test applications, among others. It operates in Wetherby, Cambridge and London. Avacta is headquartered in Wetherby, the UK.

Avacta Group Plc (AVCT) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Avacta Group Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Avacta Group Plc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Avacta Group Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Avacta Group Plc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Avacta Group Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Avacta Group Plc, Medical Equipment, Deal Details 11
Partnerships 11
Two US biotech companies Enter into Licensing Agreement with Avacta 11
FIT Biotech Enters into Agreement with Avacta 12
Avacta Enters into Agreement with Mologic 13
Avacta Group Enters Into Distribution Agreement With Cold Spring Biotech 14
Equity Offering 15
Avacta Group to Raise up to USD34.2 Million in Private Placement of Shares 15
Avacta Group Completes Private Placement Of US$3 Million 16
Asset Transactions 17
Unchained Labs Acquires Optim Technology from Avacta for USD5 Million 17
Avacta Group Plc – Key Competitors 18
Avacta Group Plc – Key Employees 19
Avacta Group Plc – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 22
Financial Announcements 22
Oct 04, 2017: Avacta Group: Preliminary Results for the Year Ending 31 July 2017 22
Aug 07, 2017: Avacta Group: Trading Update and Notice of Results 23
Apr 03, 2017: Avacta Group: Interim results for the period ended 31 January 2017 25
Oct 17, 2016: Avacta Group: Preliminary Results for the Year Ended 31 July 2016 26
Apr 25, 2016: Avacta Group: Interim Results for the Period Ended 31 January 2016 28
Corporate Communications 29
Oct 02, 2017: Avacta Establishes US Business Development Team 29
Nov 07, 2016: Avacta Group: World-Leading Cancer Stem cell Expert Joins Avacta Scientific Advisory Board 30
Aug 31, 2016: Avacta Group: Change of Registered Office 31
Aug 16, 2016: Avacta expands into new facilities in Cambridge and Wetherby 32
Mar 07, 2016: Avacta Life Sciences Establishes Scientific Advisory Board 33
Jan 25, 2016: Avacta Appoints Philippe Cotrel as Chief Commercial Officer 34
Government and Public Interest 35
Jan 20, 2017: AGM business update and notice of results 35
Product News 36
Dec 10, 2017: Avacta to Present Customer Data at Major US Conference 36
Nov 15, 2017: Covance to Present Affimer Data at European Conference 37
May 10, 2017: Avacta Group: Key Affimer patent to be granted in China 38
May 10, 2017: Avacta: Key Affimer patent to be granted in China 39
Apr 03, 2017: Excellent results for Affimer technology in Industry-standard immunogenicity study using human samples 40
Other Significant Developments 41
Aug 10, 2016: Avacta and Leeds University awarded £3.8m Medical Research Council funding to develop new diagnostic tests 41
Aug 01, 2016: Avacta Group: Pre-close trading update 43
Apr 19, 2016: Affimer Therapeutic Platform Development Milestone Achieved 45
Appendix 46
Methodology 46
About GlobalData 46
Contact Us 46
Disclaimer 46

List of Tables
Avacta Group Plc, Medical Equipment, Key Facts, 2017 2
Avacta Group Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Avacta Group Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Avacta Group Plc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Avacta Group Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Avacta Group Plc, Deals By Market, 2011 to YTD 2017 9
Avacta Group Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Two US biotech companies Enter into Licensing Agreement with Avacta 11
FIT Biotech Enters into Agreement with Avacta 12
Avacta Enters into Agreement with Mologic 13
Avacta Group Enters Into Distribution Agreement With Cold Spring Biotech 14
Avacta Group to Raise up to USD34.2 Million in Private Placement of Shares 15
Avacta Group Completes Private Placement Of US$3 Million 16
Unchained Labs Acquires Optim Technology from Avacta for USD5 Million 17
Avacta Group Plc, Key Competitors 18
Avacta Group Plc, Key Employees 19
Avacta Group Plc, Other Locations 20
Avacta Group Plc, Subsidiaries 20

★海外企業調査レポート[Avacta Group Plc (AVCT)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Guangzhou Institute of Biomedicine and Health-製薬・医療分野:企業M&A・提携分析
    Summary Guangzhou Institute of Biomedicine and Health (GIBH) is a research institute that conducts research on stem cell and regenerative medicine, chemical biology, infection and immunity, public health and scientific research equipment development. The institute’s life process and disease mechanis …
  • Booz Allen Hamilton Holding Corporation (BAH):企業の財務・戦略的SWOT分析
    Booz Allen Hamilton Holding Corporation (BAH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • GR. Sarantis S.A.:企業の戦略・SWOT・財務情報
    GR. Sarantis S.A. - Strategy, SWOT and Corporate Finance Report Summary GR. Sarantis S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Shinsei Bank Ltd:戦略・SWOT・企業財務分析
    Shinsei Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary Shinsei Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Maersk Line AS:企業の戦略的SWOT分析
    Maersk Line AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • NGK Insulators Ltd (5333):企業の財務・戦略的SWOT分析
    NGK Insulators Ltd (5333) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Covalon Technologies Ltd (COV):製品パイプライン分析
    Summary Covalon Technologies Ltd (Covalon) is a researcher, developer and commercialization of medical devices and healthcare technologies. The company offers advanced wound solutions, infection prevention products and perioperative care products. Covalon offers wound care products such as collagen …
  • XsunX Inc (XSNX):企業の財務・戦略的SWOT分析
    XsunX Inc (XSNX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Terex Corporation:企業の戦略・SWOT・財務情報
    Terex Corporation - Strategy, SWOT and Corporate Finance Report Summary Terex Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Denver Water:企業の戦略的SWOT分析
    Denver Water - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Zecotek Photonics Inc (ZMS):企業の財務・戦略的SWOT分析
    Zecotek Photonics Inc (ZMS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Hutchinson SA:企業の戦略的SWOT分析
    Hutchinson SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Clovis Oncology Inc (CLVS):医療機器:M&Aディール及び事業提携情報
    Summary Clovis Oncology Inc (Clovis) is a biopharmaceutical company that acquires, develops and commercializes new anti-cancer agents. The company's development programs are targeted at specific cancer indications, combining personalized medicine with companion diagnostics. It develops and commercia …
  • Regency Centers Corporation:企業のM&A・事業提携・投資動向
    Regency Centers Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Regency Centers Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • ADAMA Agricultural Solutions Ltd.:企業の戦略的SWOT分析
    ADAMA Agricultural Solutions Ltd. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Empresa Electricidad del Peru SA (ELECPBC1):企業の財務・戦略的SWOT分析
    Empresa Electricidad del Peru SA (ELECPBC1) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key streng …
  • Bashneft (BANE):企業の財務・戦略的SWOT分析
    Bashneft (BANE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Shire Plc (SHP)-医療機器分野:企業M&A・提携分析
    Summary Shire Plc (Shire) is a biotechnology company that focuses on the research, development, manufacturing, marketing, distribution and sale of novel pharmaceuticals to serve patients with rare diseases and other highly specialized conditions. It provides products across various therapeutic areas …
  • Oglethorpe Power Corporation:発電所・企業SWOT分析
    Oglethorpe Power Corporation - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • The Alfred Mann Foundation:製品パイプライン分析
    Summary The Alfred Mann Foundation (AMF) is a medical instutute that develops medical devices and commercializes solutions for significant medical conditions. The institute conducts research in the therapeutic areas of neuromuscular disorders, diabetes, limb loss, and chronic pain. It provides neuro …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆